ARCHIVES

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of November

November 28, 2014

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

Eight Win ASCO Young Investigator Awards

August 22, 1986

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005